На этой странице перечислены больницы направления «Кардиология» (включая Coronary Artery Bypass Grafting) в Дели (NCR), Индия, включая Apollo Hospitals, Medanta - The Medicity, Artemis Hospital, Fortis Memorial Research Institute и другие.
Спросите нас о «Coronary Artery Bypass Grafting» в Дели (NCR), Индия
Оставьте свои данные — наша команда координации свяжется с вами и расскажет о следующих шагах.
Сравните 38 аккредитованных больниц (Кардиология) в Дели (NCR), Индия
Рекомендуем🇮🇳 Apollo Hospitals
Больница занимает 1-е место в этом списке по указанному рейтингу (4.9/5, 1240 отзывов).
🇮🇳 Medanta - The Medicity
Больница занимает 2-е место в этом списке по указанному рейтингу (4.9/5, 2150 отзывов).
🇮🇳 Artemis Hospital
Больница занимает 3-е место в этом списке по указанному рейтингу (4.9/5, 64 отзывов).
🇮🇳 Fortis Memorial Research Institute
Больница занимает 4-е место в этом списке по указанному рейтингу (4.8/5, 1100 отзывов).
🇮🇳 Max Super Specialty Hospital
Больница занимает 5-е место в этом списке по указанному рейтингу (4.8/5, 1300 отзывов).
🇮🇳 All India Institute of Medical Sciences (AIIMS)
Больница занимает 6-е место в этом списке по указанному рейтингу (4.7/5, 3500 отзывов).
🇮🇳 CK Birla Hospital
Больница занимает 7-е место в этом списке по указанному рейтингу (4.7/5, 162 отзывов).
🇮🇳 Centre for Sight
Больница занимает 8-е место в этом списке по указанному рейтингу (4.7/5, 181 отзывов).
🇮🇳 Max Super Specialty Hospital, Gurgaon
Больница занимает 9-е место в этом списке по указанному рейтингу (4.6/5, 95 отзывов).
🇮🇳 Max Super Speciality Hospital, Patparganj
Больница занимает 10-е место в этом списке по указанному рейтингу (4.6/5, 97 отзывов).
🇮🇳 Primus Super Speciality Hospital
Больница занимает 11-е место в этом списке по указанному рейтингу (4.6/5, 142 отзывов).
🇮🇳 PSRI Multispeciality Hospital
Больница занимает 12-е место в этом списке по указанному рейтингу (4.6/5, 318 отзывов).
🇮🇳 Fortis Escorts Heart Institute
Больница занимает 13-е место в этом списке по указанному рейтингу (4.5/5, 24 отзывов).
🇮🇳 Fortis Hospital, Shalimar Bagh
Больница занимает 14-е место в этом списке по указанному рейтингу (4.5/5, 68 отзывов).
🇮🇳 Sarvodaya Hospital
Больница занимает 15-е место в этом списке по указанному рейтингу (4.5/5, 74 отзывов).
🇮🇳 Indian Spinal Injuries Center
Больница занимает 16-е место в этом списке по указанному рейтингу (4.5/5, 76 отзывов).
🇮🇳 Max Super Speciality Hospital, Shalimar Bagh
Больница занимает 17-е место в этом списке по указанному рейтингу (4.5/5, 82 отзывов).
🇮🇳 Fortis Hospital, Noida
Больница занимает 18-е место в этом списке по указанному рейтингу (4.5/5, 88 отзывов).
🇮🇳 Venkateshwar Hospital
Больница занимает 19-е место в этом списке по указанному рейтингу (4.5/5, 69 отзывов).
🇮🇳 CK Birla Hospital
Больница занимает 20-е место в этом списке по указанному рейтингу (4.5/5, 72 отзывов).
🇮🇳 Fortis Flt. Lt. Rajan Dhall Hospital
Больница занимает 21-е место в этом списке по указанному рейтингу (4.5/5, 75 отзывов).
🇮🇳 Asian Institute of Medical Sciences
Больница занимает 22-е место в этом списке по указанному рейтингу (4.5/5, 119 отзывов).
🇮🇳 Manipal Hospitals Dwarka
Больница занимает 23-е место в этом списке по указанному рейтингу (4.4/5, 54 отзывов).
🇮🇳 Sir Ganga Ram Hospital
Больница занимает 24-е место в этом списке по указанному рейтингу (4.4/5, 24 отзывов).
🇮🇳 Fortis Escorts Hospital
Больница занимает 25-е место в этом списке по указанному рейтингу (4.4/5, 31 отзывов).
🇮🇳 Metro Hospital and Heart Institute
Больница занимает 26-е место в этом списке по указанному рейтингу (4.4/5, 63 отзывов).
🇮🇳 Marengo Asia Hospitals
Больница занимает 27-е место в этом списке по указанному рейтингу (4.4/5, 54 отзывов).
🇮🇳 Yatharth Super Specialty Hospital
Больница занимает 28-е место в этом списке по указанному рейтингу (4.4/5, 61 отзывов).
🇮🇳 Paras Hospitals
Больница занимает 29-е место в этом списке по указанному рейтингу (4.4/5, 59 отзывов).
🇮🇳 Fortis Hospital Manesar
Больница занимает 30-е место в этом списке по указанному рейтингу (4.4/5, 74 отзывов).
🇮🇳 Marengo Asia Hospitals Gurgaon
Больница занимает 31-е место в этом списке по указанному рейтингу (4.4/5, 103 отзывов).
🇮🇳 Metro Hospital Noida
Больница занимает 32-е место в этом списке по указанному рейтингу (4.4/5, 121 отзывов).
🇮🇳 Sharda Hospital
Больница занимает 33-е место в этом списке по указанному рейтингу (4.4/5, 130 отзывов).
🇮🇳 Fortis Hospital, Greater Noida
Больница занимает 34-е место в этом списке по указанному рейтингу (4.3/5, 28 отзывов).
🇮🇳 Fortis Escorts Hospital Jaipur
Больница занимает 35-е место в этом списке по указанному рейтингу (4.3/5, 132 отзывов).
🇮🇳 Metro Hospital and Heart Institute, Noida
Больница занимает 36-е место в этом списке по указанному рейтингу (4.3/5, 138 отзывов).
🇮🇳 Max Super Speciality Hospital, Saket
Больница занимает 37-е место в этом списке по указанному рейтингу (3.8/5, 49 отзывов).
🇮🇳 BLK-Max Super Speciality Hospital
Больница занимает 38-е место в этом списке по указанному рейтингу (3.8/5, 48 отзывов).
Как мы выбираем эти больницы
Больница появляется на этой странице, если направление «Кардиология» указано среди её специализаций и она находится в Дели (NCR), Индия. Сортировка — по указанному рейтингу (по убыванию), без редакционного рейтинга «лучших».
Как выбрать лучшую больницу для «coronary artery bypass grafting» в Дели (NCR), Индия?
Выбор подходящей больницы для «coronary artery bypass grafting» — важное решение в вашем пути лечения. Вот на что стоит обратить внимание:
Международная аккредитация
Ищите больницу с международной аккредитацией, например JCI или NABH — см. отметки аккредитации у каждой больницы ниже.
Специализация
Убедитесь, что в больнице есть отделение, специализирующееся на «Кардиология», а не только общая помощь.
Мощность и опыт
Количество коек и год основания, указанные ниже, отражают масштаб и операционный опыт больницы.
Прозрачность стоимости
Запросите детализированную смету перед поездкой — используйте наш калькулятор стоимости для первичной оценки.
Что нужно знать о процедуре «Coronary Artery Bypass Grafting»
Coronary Artery Bypass Grafting (CABG) is an open-heart surgical procedure that restores adequate blood flow to the myocardium by creating new conduit pathways around blocked or severely narrowed coronary arteries, achieving symptomatic relief and improved survival in over 95% of appropriately selected patients. India and the UAE have emerged as premier destinations for international CABG patients, combining internationally accredited cardiac surgery programs, high-volume surgical teams performing 500–2,000 cases annually, and costs that are a fraction of those in Western countries. GAF Healthcare coordinates every aspect of your cardiac journey — from specialist matching and visa facilitation to post-operative rehabilitation — ensuring clinical excellence and seamless logistical support whether you choose India or the UAE. Hospital Stay: 7–10 days (including 1–2 days in the Cardiac ICU followed by monitored step-down ward care) • Total Stay in Country (Fit-to-Fly): 4–6 weeks (international long-haul flight clearance typically granted after sternal wound healing is confirmed and cardiopulmonary stability is established) • Success Rate: 95–98% (30-day operative survival in elective, isolated CABG at accredited Indian and UAE centers)
Clinical Overview
Coronary artery disease (CAD) results from the progressive accumulation of atherosclerotic plaques within the epicardial coronary arteries, causing luminal stenosis that restricts oxygen delivery to the myocardium. When one or more vessels are critically narrowed — typically defined as ≥70% stenosis in a major vessel or ≥50% in the left main coronary artery — the resulting ischemia manifests as stable angina, unstable angina, or, in acute presentations, myocardial infarction. Left untreated or inadequately managed, multivessel CAD significantly impairs left ventricular function, increases the risk of life-threatening arrhythmias, and carries an annual mortality rate that can exceed 3–5% in high-burden disease. CABG is the guideline-recommended revascularization strategy (Class I, Level A evidence per ESC/ACC/AHA guidelines) for patients with left main disease, three-vessel CAD — particularly with reduced ejection fraction — or complex multivessel disease with high SYNTAX scores (>22) where percutaneous coronary intervention (PCI) offers inferior long-term durability. The procedure involves harvesting arterial or venous conduits — most commonly the left internal mammary artery (LIMA), right internal mammary artery (RIMA), radial artery, or saphenous vein graft (SVG) — and anastomosing them to the coronary arteries distal to the obstructions, effectively bypassing the diseased segments and restoring physiological coronary perfusion. The standard of care at high-volume cardiac centers in India and the UAE encompasses a multidisciplinary Heart Team approach (interventional cardiologist, cardiac surgeon, anesthesiologist, intensivist, and rehabilitation specialist) that mirrors protocols at institutions such as the Cleveland Clinic and Johns Hopkins. Preoperative risk stratification using validated tools — the EuroSCORE II, STS Score, and SYNTAX Score — guides conduit selection, operative planning, and the decision between on-pump and off-pump techniques. Postoperative management adheres to evidence-based pharmacotherapy including dual antiplatelet therapy (aspirin plus clopidogrel for venous grafts), high-intensity statin therapy, beta-blockers, ACE inhibitors, and structured cardiac rehabilitation programs beginning as early as postoperative day 2.
Who is a Candidate?
• ELIGIBLE CANDIDATES (INDICATIONS): • Significant left main coronary artery stenosis (≥50%) regardless of symptom severity • Three-vessel CAD with or without proximal LAD involvement, especially with SYNTAX Score >22 • Two-vessel or three-vessel CAD with diabetes mellitus (CABG demonstrates superior 5-year outcomes over PCI in diabetic multivessel disease — FREEDOM trial data) • Reduced left ventricular ejection fraction (LVEF <35–40%) with viable myocardium confirmed on imaging • Failed or unsuitable anatomy for PCI (heavily calcified vessels, bifurcation lesions not amenable to stenting, chronic total occlusions) • Recurrent in-stent restenosis or prior failed PCI • Combined valvular and coronary disease requiring concomitant surgical correction • Acute coronary syndrome with cardiogenic shock or mechanical complications not responsive to percutaneous intervention • REQUIRED PRE-OPERATIVE DIAGNOSTICS: • Coronary angiography (gold standard; CT coronary angiography as non-invasive alternative in select patients) • 2D Echocardiography (ECHO) — assessment of LVEF, wall motion abnormalities, valve function, and pericardial status • Myocardial viability assessment: Nuclear stress test (Tc-99m SPECT), Cardiac MRI with late gadolinium enhancement, or PET-CT (FDG-PET for hibernating myocardium in low-EF patients) • Pulmonary function tests (PFTs) — critical for patients with concurrent COPD • Carotid Doppler ultrasound — to rule out significant carotid stenosis before placing on cardiopulmonary bypass • Lower limb venous Doppler — pre-harvest assessment of saphenous vein quality • Complete blood panel: CBC, coagulation profile (PT/INR, aPTT), renal function, HbA1c, lipid panel, thyroid function • Chest X-ray and 12-lead ECG • HLA typing and infectious serology (HIV, HBsAg, HCV, VDRL) as per institutional protocol • CONTRAINDICATIONS AND HIGH-RISK FACTORS: • Severely depressed LVEF (<20%) without demonstrated myocardial viability on PET-CT or cardiac MRI • End-stage renal disease on dialysis (significantly elevated operative risk; surgery may still proceed at specialized centers with careful planning) • Severe, irreversible pulmonary hypertension • Active systemic infection or bacteremia • Severely calcified (porcelain) aorta — markedly increases embolic risk with aortic cross-clamping; may require off-pump or alternative cannulation strategies • Uncorrectable bleeding diathesis or inability to tolerate anticoagulation • EuroSCORE II or STS predicted mortality >10–15% in elective settings (relative contraindication; Heart Team consensus required)
Treatment Options & Approaches
SURGICAL TECHNIQUES FOR CABG: 1. CONVENTIONAL ON-PUMP CABG (Standard Approach): The most widely performed technique, utilizing cardiopulmonary bypass (CPB) with a heart-lung machine and cardioplegic cardiac arrest (cold blood or del Nido cardioplegia). This provides a bloodless, motionless operative field optimal for complex multi-vessel anastomoses. The sternum is accessed via a median sternotomy. LIMA-to-LAD anastomosis — the cornerstone of durable CABG — achieves 10-year patency rates exceeding 90%, compared to approximately 60–70% for saphenous vein grafts. Total arterial revascularization (LIMA + RIMA + radial artery) is preferred in younger patients (<65 years) to maximize long-term graft patency. 2. OFF-PUMP CABG (OPCAB — Beating Heart Surgery): Performed on a beating heart using tissue stabilizer devices (e.g., Medtronic Octopus, Guidant Ultima) without CPB. OPCAB eliminates CPB-related systemic inflammatory response, reduces risk of neurological complications (postoperative cognitive dysfunction, stroke), and is particularly advantageous in patients with severely calcified aortas, renal insufficiency, or advanced age. Multiple studies (ROOBY, CORONARY trials) demonstrate equivalence in mortality with potential benefit in high-risk subgroups. Requires a highly experienced surgical team for complex multi-vessel cases. 3. MINIMALLY INVASIVE DIRECT CORONARY ARTERY BYPASS (MIDCAB): Accesses the heart via a small left anterior thoracotomy (5–8 cm incision) without sternotomy. Typically used for isolated LIMA-to-LAD bypass in patients with single-vessel LAD disease or as a hybrid strategy combined with PCI for non-LAD vessels. Benefits include shorter hospital stay, faster recovery, reduced blood loss, and superior cosmetic outcome. Not suitable for complex multi-vessel disease. 4. TOTALLY ENDOSCOPIC / ROBOTIC-ASSISTED CABG (TECAB): Utilizes robotic surgical platforms (da Vinci Surgical System) to perform completely endoscopic coronary anastomoses through port-site incisions of 8–12 mm. Achieves LIMA-to-LAD anastomosis with precision comparable to open surgery, with minimal tissue trauma and significantly accelerated recovery. Available at select high-volume centers in India (Narayana Health, Apollo Hospitals) and the UAE (Cleveland Clinic Abu Dhabi). Most appropriate for single or double-vessel disease in non-obese patients with favorable anatomy. 5. HYBRID CORONARY REVASCULARIZATION (HCR): A combined strategy where the cardiac surgeon performs a MIDCAB or robotic LIMA-to-LAD bypass (providing the most durable conduit to the most critical vessel), followed by PCI with drug-eluting stents (DES) for the remaining non-LAD lesions. This approach maximizes durability of LAD revascularization while minimizing surgical trauma for additional vessels. Particularly suited for patients with complex anatomy not amenable to full surgical revascularization or those wishing to avoid full sternotomy. 6. CONDUIT SELECTION STRATEGY: • LIMA-to-LAD: Gold standard; mandatory in virtually all CABG cases in appropriate anatomy • Bilateral Internal Mammary Arteries (BIMA): Superior long-term survival vs. single IMA; used cautiously in diabetics due to increased sternal wound infection risk (mitigated by skeletonization harvesting technique) • Radial Artery: Excellent 10-year patency (>80%) when bypassing vessels with ≥70% stenosis; requires pre-op Allen test or Doppler to confirm ulnar artery adequacy • Saphenous Vein Graft (SVG): Widely available; inferior long-term patency; endoscopic vein harvesting (EVH) reduces leg wound complications 7. CONCOMITANT PROCEDURES: CABG is frequently combined with mitral valve repair/replacement, surgical ventricular restoration (SVR/Dor procedure) for large anterior aneurysms, ablation procedures for concurrent atrial fibrillation (Cox-Maze IV), or septal myectomy in hypertrophic obstructive cardiomyopathy.
Восстановление
PRE-OPERATIVE PHASE (Days -7 to -1): • Day -7 to -5: Remote consultation with GAF Healthcare's cardiac surgery team. Upload and review of all existing investigations (coronary angiography films, echo reports, prior catheterization data). EuroSCORE II and SYNTAX Score calculated. Surgical approach and conduit strategy discussed with the patient and family. • Day -5 to -3: Arrival in India or UAE. Airport transfer arranged by GAF Healthcare. Admission to partner hospital or pre-admission outpatient evaluation. Repeat or supplementary diagnostics performed if required (carotid Doppler, viability study, PFTs). Anesthesia pre-assessment and optimization of comorbidities (glycemic control targeting HbA1c <7.5%, antihypertensives, discontinuation of anticoagulants per protocol). • Day -2 to -1: Pre-operative optimization completed. Informed consent obtained with language-specific interpreter provided by GAF Healthcare. Bowel preparation, skin preparation, and sternal antiseptic protocol initiated. Chest physiotherapy teaching (IS — Incentive Spirometry) commenced. Patient NPO (nil per os) from midnight. PROCEDURE DAY (Day 0): • General anesthesia induced; intraoperative transesophageal echocardiography (TEE) used for real-time cardiac function monitoring. • Conduit harvesting performed simultaneously by assisting surgical team (endoscopic vein harvest from leg; skeletonized LIMA/RIMA takedown). • Median sternotomy performed; systemic heparinization for CPB or OPCAB stabilization device deployed. • Distal anastomoses completed first (typically LIMA-to-LAD, then sequential or individual grafts to other vessels), followed by proximal anastomoses to aorta. • Protamine administered to reverse heparin; hemostasis confirmed; sternal closure with stainless steel wires; layered soft tissue closure. • Procedure duration: 3–5 hours for standard 3-vessel CABG; 5–7 hours for complex cases or concomitant valve surgery. • Patient transferred to Cardiac ICU (CICU) on mechanical ventilation. POST-OPERATIVE PHASE — HOSPITAL (Days 1–9): • Day 1 (CICU): Extubation targeted within 6–8 hours (fast-track anesthesia protocol). Hemodynamic monitoring via arterial line, central venous catheter, and pulmonary artery catheter if required. Chest drain output monitored. Initiation of aspirin (325 mg loading dose for SVG patency). • Day 2–3: Chest drains and urinary catheter removed. Patient mobilized to sitting and standing. Cardiac rehabilitation Phase I begins: deep breathing exercises, incentive spirometry, assisted ambulation. • Day 4–5: Transfer to step-down cardiac ward. Ambulation with physiotherapist to 100–200 meters. Oral pharmacotherapy consolidated: aspirin, high-intensity statin (rosuvastatin 40 mg or atorvastatin 80 mg), beta-blocker (metoprolol succinate), ACE inhibitor/ARB, and anticoagulation if indicated (post-AF or low-EF). • Day 6–7: Wound inspection and dressing change. Sternal stability confirmed. Dietary counseling and cardiac diet education. Blood sugar optimization in diabetic patients. • Day 8–9: Pre-discharge echocardiography. Discharge blood panel (CBC, renal function, INR). Discharge medications prescribed; patient and family educated on sternal precautions, activity restrictions, warning signs (fever, wound dehiscence, palpitations, chest pain). • Discharge: Day 8–10 post-operatively for uncomplicated cases. POST-OPERATIVE PHASE — OUTPATIENT IN-COUNTRY (Weeks 2–6): • Week 2–3: Follow-up wound clinic visit. Staple/suture removal. Chest X-ray to assess pleural effusion or pneumothorax resolution. ECG and basic blood work. Activity progression: walking 20–30 minutes daily at a comfortable pace. • Week 3–4: Cardiology outpatient review. Echocardiography if LVEF was depressed pre-operatively. Neurological assessment if cognitive concerns. Introduction of structured Phase II cardiac rehabilitation. • Week 4–6: Fit-to-fly assessment. International flight cleared only when: (a) sternal wound is fully healed with no signs of infection; (b) no symptomatic pleural effusion; (c) no significant arrhythmia; (d) patient can walk 200 meters without dyspnea or angina; (e) no requirement for IV medications. Long-haul flights (>6 hours) require additional precautions: compression stockings, aspirin, and periodic ambulation in the cabin. RECOVERY MILESTONES AT HOME (Weeks 6–12): • Week 6: Light household activities resumed; driving permitted when patient can perform emergency braking without sternal pain (typically 6–8 weeks). • Week 8–10: Return to sedentary/desk work; Phase III outpatient cardiac rehabilitation commenced with cardiologist in home country. • Week 12: Most patients report significant improvement in exercise tolerance and quality of life. Repeat stress test or functional imaging at 3 months in selected cases. • Month 3–6: Return to moderate physical activity; sexual activity generally safe from week 6–8 (sternal precautions apply). • Month 12: Annual cardiology follow-up with lipid panel, renal function, HbA1c, and stress imaging if symptomatic.
Возможные риски
CABG is a major cardiac surgical procedure and carries inherent risks that vary significantly based on patient baseline health, operative complexity, and the experience of the surgical center. Patients and families should be counseled on the following specific considerations: Perioperative risks (occurring within 30 days of surgery) include stroke or transient ischemic attack (TIA), reported in 1–3% of on-pump cases and slightly lower with OPCAB; the mechanism is primarily aortic atheroembolism or air embolism during CPB. Post-operative cognitive dysfunction (POCD) — a subtle decline in memory and concentration — occurs in 20–40% of patients at discharge but resolves in the majority by 3–6 months; patients with pre-existing cerebrovascular disease, advanced age, or prolonged bypass times are at highest risk. Cardiac complications include perioperative myocardial infarction (1–5%), most often due to graft kinking, competitive flow, or technical anastomotic issues. New-onset atrial fibrillation (AF) occurs in 20–40% of patients in the first 72 hours post-operatively; this is managed with rate control (beta-blockers, amiodarone) and anticoagulation, and typically resolves within days to weeks. Low cardiac output syndrome may require temporary intra-aortic balloon pump (IABP) or Impella support in patients with severely reduced pre-operative LVEF. Surgical site complications include deep sternal wound infection (mediastinitis) in 0.5–2% of cases; risk is higher with bilateral IMA harvest (particularly in obese diabetic patients), and is mitigated by skeletonized harvesting, tight glycemic control, and prophylactic negative pressure wound therapy. Leg wound complications from open SVH occur in up to 10% of patients; endoscopic vein harvesting (EVH) reduces this substantially. Respiratory complications include atelectasis (common, managed with aggressive physiotherapy), pleural effusion (requiring drainage in approximately 3–5% of patients), and rarely pneumonia or prolonged mechanical ventilation. Acute kidney injury (AKI) occurs in 5–10% of cases and is usually transient; patients with pre-existing CKD are at significantly higher risk and require careful perioperative fluid and hemodynamic management. Long-term considerations include graft failure: saphenous vein grafts have a 10-year patency of approximately 50–60%, compared to >90% for LIMA-to-LAD. Progressive disease in native coronaries and non-bypassed segments may necessitate repeat revascularization in 5–10% of patients at 10 years. Adherence to aggressive secondary prevention — statins, antiplatelets, blood pressure control, diabetes management, smoking cessation, and cardiac rehabilitation — is the single most important determinant of long-term CABG benefit and graft longevity. All patients managed through GAF Healthcare undergo rigorous pre-operative risk stratification using validated scoring systems (EuroSCORE II, STS Score) and are operated upon only at JCI/NABH or JCI/DHA accredited institutions with documented low complication rates and high-volume surgical experience.
Почему GAF Healthcare
GAF Healthcare provides comprehensive end-to-end logistical and coordination services for international CABG patients traveling to India or the UAE, ensuring that no patient or family member navigates the administrative or travel process alone. VISA & ENTRY DOCUMENTATION: For India: GAF Healthcare facilitates the Indian e-Medical Visa (eMV), which is specifically designated for patients traveling for medical treatment and is available to nationals of over 150 countries. The eMV is valid for 60 days per visit (extendable), allows up to 3 entries, and can be obtained online within 72–96 hours with a letter of medical appointment from the treating hospital — which GAF Healthcare provides. An e-Medical Attendant Visa (eMAV) is simultaneously obtained for up to 2 accompanying family members at no additional complexity. For the UAE (Dubai/Abu Dhabi): Citizens of GCC countries, most European nations, the US, UK, Canada, and Australia receive visa-on-arrival or 30–90 day visa-free access. Patients from countries requiring a pre-arranged visa are supported by GAF Healthcare's UAE coordination team, who work with the hospital's International Patient Services department to issue official medical invitation letters accepted by UAE immigration for rapid visa processing. Dubai's position as a global aviation hub means most international patients can reach the UAE within a single-connection flight from virtually any origin. AIRPORT TRANSFERS & IN-COUNTRY TRANSPORT: Dedicated private ambulance or wheelchair-accessible vehicle transfers from the airport to the hospital are arranged for all arriving patients, regardless of clinical status. All inter-facility transfers (hotel to clinic, clinic to hospital for admission, hospital to hotel during outpatient recovery) are coordinated by GAF Healthcare's on-ground team in each city. MEDICAL TRANSLATION & INTERPRETATION: GAF Healthcare provides certified medical interpreters for Arabic, Russian, French, Swahili, Bengali, Uzbek, Kazakh, and other languages on request — both in-person (for ICU family consultations, consent discussions, discharge counseling) and via telephone/video for out-of-hours support. All medical reports, discharge summaries, and investigation results are translated into the patient's preferred language before departure. ACCOMMODATION FOR ATTENDANTS: GAF Healthcare partners with hotels and serviced apartments located within 5–15 minutes of each partner hospital. Attendant accommodation packages are offered at negotiated rates, including daily housekeeping, Wi-Fi, and meal options. For patients with complex post-operative courses, GAF Healthcare can arrange medical-grade recovery apartments with nursing support. In-hospital attendant cots or sofa beds are also arranged within the patient's room where hospital policy permits. POST-DISCHARGE FOLLOW-UP COORDINATION: Before the patient departs their destination country, GAF Healthcare prepares a comprehensive discharge package: the operative report, complete investigation records, echocardiography images, medication prescriptions (with generic international equivalents identified), and a structured follow-up plan for the patient's cardiologist at home. Telemedicine follow-up appointments with the treating cardiac surgeon at weeks 4 and 8 post-discharge are included as standard in GAF Healthcare's service model, enabling seamless continuity of care across borders.
Частые вопросы о процедуре «Coronary Artery Bypass Grafting»
What is the cost of Coronary Artery Bypass Grafting (CABG) in India vs. the UAE?
How long do I need to stay in the country before I am fit to fly home after CABG?
What is the success rate of CABG surgery at Indian and UAE centers?
Похожие страницы
Как GAF Healthcare помогает выбрать лучшую больницу для «coronary artery bypass grafting» в Дели (NCR), Индия
Найдите лучшие больницы для «coronary artery bypass grafting» в Дели (NCR), Индия
На этой странице представлено 38 больниц в Дели (NCR), Индия, чтобы вы могли сравнить аккредитацию и специализации в одном месте.
Поддержка, когда она нужна
Отправьте нам свои медицинские отчёты в WhatsApp или по email — наша медицинская команда изучит их и предложит больницу и план лечения.
Прозрачные, всё включено цены
Мы предоставляем единую детализированную смету, покрывающую расходы больницы и проживание — без скрытых платежей.
Организация визы, поездки и проживания
После выбора больницы мы помогаем оформить визовое приглашение, забронировать проживание рядом с больницей и организовать трансфер.
Хотите узнать примерную стоимость лечения? Используйте наш калькулятор стоимости для персональной оценки.
Частые вопросы о «Coronary Artery Bypass Grafting» в Дели (NCR), Индия
Сколько больниц направления «Кардиология» представлено в Дели (NCR), Индия?
Как вы выбираете больницы для списка?
Сколько стоит лечение в Дели (NCR), Индия?
Следующий шаг
Отправьте нам свои медицинские отчёты — наша команда предложит больницу и план лечения для «Coronary Artery Bypass Grafting» в Дели (NCR), Индия.
Свяжитесь с нами, если заметите неточность на этой странице.